Q3 2024 consolidated sales rose 4.7% YoY to 4.49 trillion KRW, with net income up 283.8% and operating profit down 79.8%. Major M&A, asset sales, and a completed US Phase 3 trial for TG-C highlight the period, while high leverage and ongoing litigation remain key risks.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.